Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-valvular Atrial Fibrillation (NVAF)”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Not applicableStudy completedNCT04174859
What this trial is testing

Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment

Who this might be right for
Non-valvular Atrial Fibrillation
Bayer 812
Not applicableLooking for participantsNCT05204212
What this trial is testing

Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF): Paroxysmal, Persistent, Permanent
Prof. Dr. med. Ingo Eitel 430
Not applicableStudy completedNCT01598051
What this trial is testing

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 741
Not applicableStudy completedNCT03285373
What this trial is testing

This Study Observes the Use of New Oral Anticoagulants (NOACs) in Patients With a Heart Rhythm Disorder in Spain

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,008
Not applicableStudy completedNCT04356989
What this trial is testing

Study to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal Function

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 493
Not applicableStudy completedNCT05027061
What this trial is testing

Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan

Who this might be right for
Non-Valvular Atrial Fibrillation (NVAF)
Bristol-Myers Squibb 11,776
Not applicableStudy completedNCT02631057
What this trial is testing

Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 4,313
Not applicableStudy completedNCT03570047
What this trial is testing

Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 73,989
Not applicableStudy completedNCT03508271
What this trial is testing

Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure

Who this might be right for
Atrial FibrillationHeart Failure
Bristol-Myers Squibb 60,000
Not applicableStudy completedNCT05471505
What this trial is testing

Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 120,722
Not applicableStudy completedNCT02663076
What this trial is testing

Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)Chronic Kidney Disease (CKD)
GWT-TUD GmbH 1,700
Not applicableStudy completedNCT03746301
What this trial is testing

Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 924
Early research (Phase 1)Active Not RecruitingNCT06725355
What this trial is testing

To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
HK inno.N Corporation 60
Not applicableStudy completedNCT05232643
What this trial is testing

A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation

Who this might be right for
Non-Valvular Atrial Fibrillation (NVAF)
Bristol-Myers Squibb 636
Not applicableStudy completedNCT03887780
What this trial is testing

Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF)

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 504
Not applicableUnknownNCT03554837
What this trial is testing

Safety and Effectiveness of Low Dose Edoxaban in Patients With NVAF

Who this might be right for
Atrial Fibrillation
Samsung Medical Center 2,562
Not applicableStudy completedNCT06606275
What this trial is testing

The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With NVAF/ VTE and ESKD on Dialysis

Who this might be right for
End-Stage Kidney Disease (ESKD)Non-valvular Atrial Fibrillation (NVAF)Venous Thromboembolism (VTE)
Abu Dhabi Health Services Company 67
Large-scale testing (Phase 3)Study completedNCT02164864
What this trial is testing

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

Who this might be right for
Atrial FibrillationPercutaneous Coronary Intervention
Boehringer Ingelheim 2,725
Not applicableWithdrawnNCT02153424
What this trial is testing

Early Post-marketing Study of Eliquis (Apixaban)

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00938730
What this trial is testing

A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Astellas Pharma Inc 1,280
Load More Results